4
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0001628280-19-012045
Director acquired 37,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lynch Thomas G Director | 2019-09-30 | Option exercise | +37,500 | 250,000 | D | ||
| Derivatives | |||||||
| Lynch Thomas G Director | 2019-09-30 | Option exercise · Restricted Stock Units | −37,500 | 75,000 | D | ||
Loading xslF345X03/wf-form4_156994532484636.xml…